Back to
Duquesne Family Office LLC
BEAM
2 quarters
Position history for
Duquesne Family Office LLC's holdings in Beam Therapeutics Inc.
Yes. Duquesne Family Office holds 699,700 shares of BEAM (Beam Therapeutics), worth $17.1M, as of its Q3 2026 13F filing. It increased the position from 153,600 shares in Q2 2026. Duquesne Family Office has held BEAM since Q2 2026, across 2 quarterly 13F filings. BEAM is 0.4% of Duquesne Family Office's reported 13F portfolio.
Current Value
$17.1M
Current Shares
699,700
Total Value Change
+$11.8M
Total Shares Change
+546,100
Quarter-by-Quarter History
Other major holders of BEAM: FMR LLC, ARK Investment Management LLC